The global diffuse large B-cell lymphoma therapeutics market is experiencing significant growth, fueled by a elevated prevalence of the disease and advancements in treatment options. The market is characterized by a wide-ranging landscape of players, including established pharmaceutical companies and emerging biotech firms. Key influencers shaping